Is Individualized Medicine More Cost-Effective? A Systematic Review

Background Individualized medicine (IM) is a rapidly evolving field that is associated with both visions of more effective care at lower costs and fears of highly priced, low-value interventions. It is unclear which view is supported by the current evidence. Objective Our objective was to systematic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2014-05, Vol.32 (5), p.443-455
Hauptverfasser:	Hatz, Maximilian H. M., Schremser, Katharina, Rogowski, Wolf H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Chemotherapy Chromosomes Cost analysis Cost-Benefit Analysis Economics, Medical General populations Genes Genetic testing Health Administration Health Care Costs Health care delivery Health care expenditures Health Economics Humans Intervention Medical economics Medical sciences Medical Subject Headings-MeSH Medicine Medicine & Public Health Pharmacoeconomics and Health Outcomes Precision medicine Precision Medicine - economics Prevention and actions Public Health Public health. Hygiene Public health. Hygiene-occupational medicine Quality of Life Research Quality-Adjusted Life Years Sensitivity analysis Studies Subject heading schemes Systematic Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!